CMO, director of clinical research at Frontier Dermatology in Mill Creek, Washington, discussed studies presented at Maui Derm 2026 that examined high-impact psoriasis sites.

Clearer, smoother, glowier skin is just a spritz away.

Less-than-perfect skin has always plagued adolescence, and now it happens at a time when kids are interested in posting selfies and fitting in with their peers. It can be tempting ...

Scalp odor can be a hygiene issue — or it can be a sign of an underlying scalp condition. For some people, a musty, sour, or yeasty smell emanating from the scalp may be due to excess oil and sweat, ...

Ramadan is a time when people fast from dawn until sunset. However, fasting, going long hours without water, and general changes in routine can affect your skin. It’s important to have a good skincare ...

In clinical trials, more than half of all patients treated with deucravacitinib achieved at least 20% improvement in American College of Rheumatology response criteria.

The FDA has accepted a Biologics License Application for imsidolimab to treat generalized pustular psoriasis, a rare inflammatory skin condition.

The FDA granted the approval following findings from the pivotal POETYK PsA-I and POETYK PsA-II Phase III studies.

Bristol Myers won FDA approval for Sotyktu in active psoriatic arthritis, expanding its oral immunology franchise despite a slight after-hours stock dip.

New data specific to patients with skin of color expands evidence supporting strong efficacy and safety for clascosterone ...

Executives from Alumis (NASDAQ:ALMS) outlined upcoming regulatory milestones and provided additional context around recently ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...